Levetiracetam
Product Images NDC 33261-646

11 FDA label images from Aidarex Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 33261-646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 0 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 1)

Image 0 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 1)
An illustration showing the formula to calculate the total daily dose (mL/day) of Levetiracetam oral solution. The formula is: (Daily dose in mg/kg/day) multiplied by patient weight in kg, divided by the concentration of 100 mg/mL.*
FDA Label Image

Image Label (Levetiracetam 250mg 500mg 750mg Tab For Lupin 10)

Image Label (Levetiracetam 250mg 500mg 750mg Tab For Lupin 10)
Label for Levetiracetam 500 mg tablets from Aidarex Pharmaceuticals LLC. The label indicates a package size of 30 tablets, each containing 500 mg of Levetiracetam in a film-coated form. It includes usage instructions spaces and specifies the generic manufacturer as Lupin Ltd., Goa, India. The label also features the NDC 33261-0645-30 and Rx number QLS0000.*
FDA Label Image

Image Label (Levetiracetam 250mg 500mg 750mg Tab For Lupin 11)

Image Label (Levetiracetam 250mg 500mg 750mg Tab For Lupin 11)
Levetiracetam 750 mg tablet label from Aidarex Pharmaceuticals LLC. The label states the product contains 60 film-coated, orange oval tablets with a score line on one side and markings on the reverse. The label includes the generic name, strength, tablet count, and manufacturer Lupin Limited Goa India, with NDC 33261-0646-60.*
FDA Label Image

Image 1 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 2)

Image 1 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 2)
A text panel showing formulas for calculating creatinine clearance (CLcr), including adjustments for age, weight, serum creatinine, gender, and body surface area (BSA). The formulas involve multiplying and dividing these variables to determine CLcr in mL/min.*
FDA Label Image

Image 2 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 3)

Image 2 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 3)
Chemical structure diagram of the active ingredient Levetiracetam, displaying its molecular composition and bonding arrangement.*
FDA Label Image

Image 3 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 4)

Image 3 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 4)
A bar graph showing the percentage of patients for three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). The y-axis represents the percentage of patients from 0% to 45%, and the x-axis lists the groups with sample sizes for each. Asterisks mark the percentages for Levetiracetam groups.*
FDA Label Image

Image 4 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 5)

Image 4 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 5)
A bar chart showing the percentage of patients in three groups: Placebo (6.3%), Levetiracetam 1000 mg/day (20.8%), and Levetiracetam 2000 mg/day (35.2%). The chart compares patient response rates, labeling group sizes as N=111, N=106, and the percentages are displayed above each bar.*
FDA Label Image

Image 5 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 6)

Image 5 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 6)
A bar graph comparing the percentage of patients between two groups: Placebo (N=104) with 14.4%, and Levetiracetam 3000 mg/day (N=180) with 39.4%. The y-axis represents the percentage of patients, ranging from 0% to 45%. An asterisk marks the bar for Levetiracetam.*
FDA Label Image

Image 6 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 7)

Image 6 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 7)
A bar chart comparing the percentage of patients between two groups: Placebo (97 patients) and Levetiracetam (101 patients). The chart shows 19.6% of patients in the placebo group and 44.6% in the Levetiracetam group, with the y-axis representing the percentage of patients.*
FDA Label Image

Image 7 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 8)

Image 7 (Levetiracetam 250mg 500mg 750mg Tab For Lupin 8)
A bar graph comparing the percentage of patients in two groups: Placebo (N=84) and Levetiracetam (N=79). The Placebo group shows 45.2% and the Levetiracetam group shows 72.2%, indicating a higher percentage for patients in the Levetiracetam group.*
FDA Label Image

Image Label (Levetiracetam 250mg 500mg 750mg Tab For Lupin 9)

Image Label (Levetiracetam 250mg 500mg 750mg Tab For Lupin 9)
Levetiracetam 250 mg film-coated tablet bottle label from Aidarex Pharmaceuticals LLC. The label states 30 tablets per container with each tablet containing 250 mg of levetiracetam. The generic name Keppra is mentioned along with the NDC 33261-0644-30. Manufactured by Lupin Limited Goa, India. The label includes dosing instructions with blanks for frequency and quantity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.